Atrial Fibrillation Trial, Recruiting NCT07515040 Sponsor: Second Affiliated Hospital of Nanchang University Condition: Atrial Fibrillation
Back to Atrial Fibrillation

Atrial Fibrillation Trial, Recruiting

NCT07515040
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 75 years old (inclusive)
  • You have been diagnosed with atrial fibrillation (an irregular heartbeat condition), your doctor has recommended a procedure called radiofrequency ablation, and you are already scheduled to have it
  • You are willing to take part in the trial and have signed a consent form agreeing to participate
  • You are willing to follow the trial's requirements and attend all necessary follow-up appointments
  • A heart scan (echocardiography) done before the procedure has confirmed that a specific part of your heart wall (called the fossa ovalis) has a normal structure

Who may not be able to join:

  • You have a history of a hole in the heart (patent foramen ovale or atrial septal defect), or you have previously had surgery to close a hole in the heart, had a heart valve replaced, or had a permanent pacemaker fitted
  • You have a bulging or balloon-like section of the wall between the upper chambers of your heart (atrial septal aneurysm) or an open channel between those chambers (patent foramen ovale) found during pre-procedure checks
  • During the procedure itself, if unexpected differences in your heart's anatomy are found that require switching to a different type of imaging guidance (X-ray), you would need to be withdrawn from the trial (confirm with trial site)

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 8 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Second Affiliated Hospital of Nanchang University
Registry
ClinicalTrials.gov
Start date
26 February 2025
Est. completion
26 February 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

First-pass success rate of transseptal puncture; transseptal puncture procedure time

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov